Instil Bio

Instil Bio Appoints ‘Seasoned’ Biopharma Exec as Chief Medical Officer

by | Jun 5, 2025
Dallas' Instil Bio said that Jamie Freedman has extensive experience in oncology drug development and other therapeutic areas, along with a track record of leading programs through all phases of development, regulatory approval, and commercialization.
MORE
DI People: UNT Health Science Center, McKesson, Cyrus One, and More Make Leadership Moves
by | Sep 16, 2022
In this week’s roundup of hires, promotions, and accolades in North Texas, you’ll also find news from Jacobs, HF Sinclair and Holly Energy Partners, Caris Life Sciences, Fossil Group, Deloitte, TRG, Invited, Instil Bio, RealPage, Critical Start, Genuine Article, and others.
MORE
Follow the Money: OxeFit Lands New Celebrity Backers, Dallas Biotech Raises $10M to Fight Cancer, Blockchain Investor Raises New Fund-of-Funds, and More
by | May 17, 2022
What companies are finding funding or having a big exit? From startup investments to grants and acquisitions, Dallas Innovates tracks what’s happening in North Texas money.
MORE